Affiliation:
1. Department of Obstetrics, Gynecology & Reproductive Sciences, Yale School of Medicine, New Haven, CT 06510, USA
Abstract
Oocyte cryopreservation (OC) is the process in which ovarian follicles are stimulated, the follicular fluid is retrieved, and mature oocytes are isolated and vitrified. Since the first successful pregnancy utilizing previously cryopreserved oocytes in 1986, OC has become increasingly utilized as an option for future biologic children in patients facing gonadotoxic therapies, such as for the treatment of cancer. Planned OC, also termed elective OC, is growing in popularity as a means to circumvent age-related fertility decline. In this narrative review, we describe both medically indicated and planned OC, focusing on the physiology of ovarian follicular loss, OC technique and risks, timing of when OC should be performed, associated financial considerations, and outcomes.
Reference132 articles.
1. Towards the global coverage of a unified registry of IVF outcomes;Fauser;Reprod. Biomed. Online,2019
2. SARTCORS (2023, March 09). Final National Summary Report. 2016–2020. Available online: https://www.sartcorsonline.com/Csr/Public?ClinicPKID=0.
3. Pregnancy after human oocyte cryopreservation;Chen;Lancet,1986
4. Oocyte, embryo and blastocyst cryopreservation in ART: Systematic review and meta-analysis comparing slow-freezing versus vitrification to produce evidence for the development of global guidance;Rienzi;Hum. Reprod. Update,2017
5. The Practice Committees of the American Society for Reproductive Medicine and the Society for Assisted Reproductive Technology (2013). Mature oocyte cryopreservation: A guideline. Fertil. Steril., 99, 37–43.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献